Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model

Endocrinology

Volumn 141, Issue 11, 2000, Pages 3993-3999

  Weekers, F ^a   Van Herck, E ^a   Isgaard, J ^a   Van den Berghe, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PRALMORELIN; RECOMBINANT GROWTH HORMONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART PERFUSION; HEART PROTECTION; HORMONE BLOOD LEVEL; HORMONE PROTEIN COMPLEX; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RABBIT; STUNNED HEART MUSCLE;

EID: 0033653460     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7768     Document Type: Article

References (45)

1. Molecular and cellular mechanisms of myocardial stunning
2. Alterations in cardiac sarcoplasmatic reticulum calcium transport in the postischemic stunned myocardium
3. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency
4. A body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
5. Cardiovascular and renal effects of growth hormone
6. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation
7. Growth hormone improves cardiac performance in experimental heart failure
8. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin adenosine triphosphatase activity of rat left ventricle
9. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure
10. Growth hormone improves cardiac function in rats with experimental myocardial infarction
11. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition
12. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
13. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction
14. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
15. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
16. A placebo-controlled study of growth hormone in patients with congestive heart failure
17. Growth-hormone-releasing hormone
18. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone
19. A receptor in pituitary and hypothalamus that functions in growth hormone release
20. Identification and characterization of a new GHRP receptor in the heart
21. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide in humans
22. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats
23. Growth hormone-independent cardioprotective effects of hexarelin in the rat
24. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
25. Ghrelin is a growth hormone acylated peptide from stomach
26. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms
27. 2+)-overload inhibitor, reduces myocardial ischemia-reperfusion injury in blood-perfused rabbit hearts
28. Heterogeneity of human growth hormone in serum
29. Fas/Fas ligand system in prolactin-induced apoptosis in rat corpus luteum: Possible role of luteal immune cells
30. The restoration of cardiac hypertrophy and blood pressure in hypophysectomized rats by large doses of lyophilized anterior pituitary and growth hormone
31. Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study
32. Growth hormone and the heart
33. Growth hormone regulates the level of insulin-like growth factor-I mRNA in the rat skeletal muscle
34. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes
35. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs
36. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH relesing peptide, in humans
37. PKC dependent preconditioning with norepinephrine protects sarcoplasmatic reticulum function in rat trabeculae following metabolic inhibition
38. 2+ overload injury in rat myocardium
39. Left ventricular regional systolic and diastolic function in conscious sheep undergoing ischemic preconditioning
40. Relation between glycolysis and calcium homoiostasis in postischemic myocardium
41. The effects of ischemic preconditioning on resting coronary flow and reactive hyperemia: Involvement of A1 adenosine receptors
42. AT1 receptor blockade in experimental ischemia/reperfusion
43. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning
44. Utilization of oxygen by the contractile apparatus is disturbed during reperfusion of postischemic myocardium
45. Reperfusion injury induces apoptosis in rabbit cardiomyocytes